A randomised controlled trial evaluating a novel cytotoxic drug delivery system for the treatment of cervical intraepithelial neoplasia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 2, 1997, Pages 145-149

  Sidhu, Harmini Kaur ^a   Price, John H ^b   McCarron, Paul A ^b   McCafferty, Dermot F ^b   Woolfson, A David ^b   Biggart, Denis ^b   Thompson, William ^b  

^a ANTRIM AREA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; PLACEBO;

ARTICLE; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX CARCINOMA IN SITU;

ADMINISTRATION, TOPICAL; ANTIMETABOLITES, ANTINEOPLASTIC; CERVICAL INTRAEPITHELIAL NEOPLASIA; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; FEMALE; FLUOROURACIL; HUMANS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 0031042780     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb11034.x     Document Type: Article

References (20)

1. Klein E. Tumours of the skin. X: Immunotherapy of cutaneous and mucosal neoplasms. N Y State J Med 1968; 68: 900–911.
2. Guthrie D, Way S. Failure of topical DNCB immunotherapy in most patients with non-clinical carcinoma of the cervix. Br J Cancer 1979; 39: 445–448.
3. Sillman FH, Boyce JG, Macasaet MA, Nicastri AD. 5-fluorouracil/chemosurgery for intraepithelial neoplasia of the genital tract. Obstet Gynecol 1981; 58: 356–360.
4. Meyskens Jr FL, Graham V, Chvapil M et al. A phase 1 trial of β-all-trans-retinoic acid delivered via a collagen sponge and a cervical cap for mild and moderate cervical neoplasia. J Natl Cancer Inst 1983; 71: 921–925.
5. Moller BR, Johannesen P, Osther K et al. Treatment of dysplasia of the cervical epithelium with an interferon gel. Obstet Gynecol 1983; 62: 625–629.
6. Romney SL, Dwyer A, Slagle S et al. Chemoprevention of cervix cancer. Phase I-1I: a feasibility study involving the topical vaginal administration of retinyl acetate gel. Gynecol Oncol 1985; 20: 109–119.
7. Peng YM, Alberts DS, Graham V et al. Cervical tissue uptake of all-trans-retinoic acid delivered via a collagen–cervical cap delivery device in patients with cervical dysplasia. Invest New Drugs 1986; 4: 245–249.
8. Pride GL, Chuprevich TW. Topical 5-fluorouracil treatment of transformation zone intraepithelial neoplasia of cervix and vagina. Obstet Gynecol 1982; 60: 467–472.
9. Kirwan P, Naftalin NJ. Topical 5-fluorouracil in the treatment of vaginal intraepithelial neoplasia. Br J Obstet Gynaecol 1985; 92: 287–291.
10. Barten G. Local treatment for cervical intraepithelial neoplasia with a 5% fluorouracil ointment. Zentralblatt fur Gynakohgie 1987; 109: 1510–1516.
11. Woolfson AD, McCafferty DF, McCarron PA, Price JH. A bioadhesive patch cervical drug delivery system for the administration of 5-fluorouracil to cervical tissue. J Controlled Release 1995; 35: 49–58.
12. Woolfson AD, McCafferty DF, McCarron PA, Price JH. Liquid scintillation spectrometry of 5-fluorouracil in cervical tissue following topical application of a bioadhesive cervical patch. Pharm Res 1994; 11: 1315–1319.
13. Myers CE, Diasio R, Elliot H. M, Chabner BA. Pharmacokinetics of thr fluorinated pyrimidines: Implications for their clinical use. Cancer Treatment Rev 1976; 3: 175–183.
14. Ismail SM, Colclough AB, Dinnen DS et al. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ 1989; 298: 707–710.
15. Robertson AJ, Anderson JM, Swanson Beck J et al. Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol 1989; 42: 231–238.
16. Campion MJ, McCance DJ, Cuzick J, Singer A. Progressive potential of mild cervical atypia: prospective cytological colposcopic and virological study. Lancet 1986; 2: 237–240.
17. Rome R, Chanen W, Pagano R. The natural history of human papillo-mavirus (HPV) atypia of the cervix. Aust N Z J Obstet Gynaecol 1987; 27: 287–290.
18. Syrjanen K, Mantyjarvi R, Vayrynen M et al. Human papillomavirus (HPV) infections involved in the neoplastic process of the uterine cervix as established by prospective follow-up of 513 women for two years. Eur J Gynecol Oncol 1987; 8: 5–16.
19. Montz FJ, Holschneider CH, Thompson DR. Large-loop excision of the transformation zone: effect on the pathologic interpretation of resection margins. Obstet Gynecol 1993; 6: 976–982.
20. Messing MJ, Otken L, King LA, Gallup DG. Large loop excision of the transformation zone: a pathologic evaluation. Gynecol Oncol 1994; 52: 207–211.